Imricor Medical Systems Inc (ASX: IMR) Share Price and News

Mr McGregor has over 30 years of experience in senior finance and management roles, including having been a partner in the investment banking firm of Goldman Sachs JBWere and a managing director in the institutional banking & markets division of Commonwealth Bank of Australia. Mr McGregor is an experienced company director, and currently serves as a Director of Treasury Corporation of Victoria and Green Eco International Limited, and is a former director of TRUE Infrastructure Management Pty Ltd, and the Brisbane Lions Australian Football Club. He is Risk Committee chair.

Mr Wedan is responsible for the overall management and strategic direction of the Company. Mr Wedan has over 30 years of experience in the medical device industry including design engineering of MRI and ultrasound systems for GE Healthcare, as well as Vice President and Chief Technology Officer for Applied Biometrics Inc. Immediately prior to co-founding Imricor, Mr Wedan founded and operated a technical consulting company, Wedan Technologies Inc., from 2000-2006. Mr Wedan is a member of international standards committees in the fields of MRI safety and the compatibility of implanted and interventional products in MRI. Mr Wedan currently serves on the Advisory Board of Poiesis Medical, LLC.

Mr Tibbles is an entrepreneur, business owner, company director and active venture investor in and advisor to technology, life science and medical device companies. Mr Tibbles is currently a Board Member of FamGenix, Inc., a provider of genetic risk assessment tools that help identify patients at hereditary risk of disease; Co-Founder and Board Member of PERMnet, Inc.; a Managing Member of STEM Fuse, LLC; and the Managing Director of Strategic Stage Ventures, LLC. Prior to his current roles, Mr Tibbles was a Board member of the Nerdery, LLC as well as an owner and member of Intuitive Technology Group until it was sold in 2017. Mr Tibbles was also a President and founder of PRC Consulting, Inc., a company in the management and implementation of IT projects for Fortune 1000 Companies, from 1998 until 2013, when PRC was sold. He is Risk Committee member.

Ms Messal is an executive with 40 years of experience across a variety of functions. With a substantial career in healthcare and benefits, she has experience in health plan services, health care delivery, care management, and benefits administration. Ms Messal has experience in public, private, and non-profit sectors, working in both domestic and international markets. She has led areas of company performance, including sales, product, operations, and technology. Her responsibilities have encompassed M&A integration, data exchange, account management, customer service, system development, information security, product development, national accounts, project management, vendor management, strategic systems, legal, human resources, and learning & development. Ms Messal has also played a role in fundraising from start-up through IPO and sale to strategic buyers and private equity. Ms Messal currently serves on the Board of Directors of Ideon as Executive Chair and is an Advisor to Poiesis Medical. She is Risk Committee member.

Dr Leighton is a cognitive neuroscientist with experience in both academic and corporate settings. He has a research, teaching, and leadership background. Beyond his academic achievements, Dr Leighton has business acumen as CFO at NDS Wellness, a regional (23 states) provider of mobile neuroimaging and wellness centers. He was in the company's growth phase, managing financial operations and working with the CEO. NDS Wellness offered comprehensive services, including mobile wellness clinics, telehealth, and health screenings, to corporations and self-insured companies. Dr Leighton has held corporate governance and advisory roles, including serving as an Institutional Review Board (IRB) member at a non profit neuromodulatory research center.

Mr Denti has over 30 years of global experience in the medical device industry. Mr Denti is currently the Chief Commercial Officer for Dentsply Sirona. Prior to this role, he was the Company Group Chairman of Global Orthopaedics for Johnson & Johnson MedTech. Since becoming Company Group Chairman in 2019, Mr Denti grew the business to US$9 billion in annual sales. Prior to his role in orthopaedics, Mr Denti served as Global Leader at Johnson & Johnson Vision, where he modernized the organization and introduced new skill sets in strategic planning, insights & analytics, e-commerce, and business model innovation. Mr Denti's other experiences include Sales and Marketing roles with companies such as DePuy, Medtronic, and Pfizer.

-

-

-

-

-

-

-

-

-

-